NCT04924140View on ClinicalTrials.gov

A Study to Assess Absolute Bioavailability of Aducanumab in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

June 30, 2021

Primary Completion Date

October 1, 2021

Study Completion Date

October 1, 2021

Conditions

Healthy Volunteers

Interventions

DRUG

Aducanumab

Administered as specified in the treatment arm

Trial Locations (2)

33143

Qps-Mra, Llc, South Miami

92801

Anaheim Clinical Trials, LLC, Anaheim

Sponsors

Lead Sponsor

All Listed Sponsors

collaborator

Eisai Co., Ltd.

INDUSTRY

lead

Biogen

INDUSTRY

NCT04924140 - A Study to Assess Absolute Bioavailability of Aducanumab in Healthy Volunteers | Biotech Hunter | Biotech Hunter